Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-08-19
1990-05-08
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548255, C07D21304
Patent
active
049238850
ABSTRACT:
Novel 5-Amino-1-(4-Naphthoylbenzyl)-1,2,3-triazole-4-carboxamides and analogs are disclosed as having antiproliferative activities useful in the treatment and control of psoriasis, inflammatory bowel syndrome, cutaneous leishmanilisis and certain types of cancer.
REFERENCES:
patent: 4227004 (1980-10-01), Wildonger
patent: 4590201 (1986-05-01), Bochis et al.
M. Bosma et al., J. Cellular Physiology, vol. 135, 317-323 (1988).
M. Berridge, Biotechnology, pp. 541-546, Jun. 1984.
M. Berridge, Scientific American, vol. 254, pp. 142-152 (1985).
E. Carofoli et al., Scientific American, vol. 263, pp. 70-78 (1985).
Hupe Donald
Wyvratt Matthew J.
Covington Raymond
DiPrima Joseph F.
Merck & Co. , Inc.
North Robert J.
Panzer Curtis C.
LandOfFree
5-amino-1-(4-naphthoylbenzyl)-1,2,3-triazole-4-carboxamides and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-amino-1-(4-naphthoylbenzyl)-1,2,3-triazole-4-carboxamides and , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-amino-1-(4-naphthoylbenzyl)-1,2,3-triazole-4-carboxamides and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2349442